Roivant Sciences: A Biotech Growth Play With Major Ambitions

Group 1 - Roivant Sciences Ltd. (NASDAQ: ROIV) is executing its "Vant" biotech business model, which allows for the rapid development and monetization of drug candidates through specialized subsidiaries [1] - The company's trials have shown promising progress since the last report, indicating potential advancements in their drug development pipeline [1]